Changjiang Qin

518 citations
17 papers · 335 indexed · h-index 12
Topics
Genetic factors in colorectal cancer (4 papers)RNA modifications and cancer (3 papers)Wnt/β-catenin signaling in development and cancer (3 papers)
Partner nations
ChinaHong Kong

In The Last Decade

Changjiang Qin

17 papers receiving 334 citations

Peers

Changjiang Qin
Comparison fields: 5 of 72
  • Molecular Biology 247
  • Cancer Research 132
  • Oncology 65
  • Pulmonary and Respiratory Medicine 34
  • Pathology and Forensic Medicine 30
Replace Chengyong Lei with:
Chengyong Lei China
Wang Li China
Yidong Cheng China
Fanjun Cheng China
Weimin Dong China
Ahmed A. Moustafa United States
Wenbin Huang China
Apple Long United States
Wendy W. Barclay United States
Changjiang Qin relative to Chengyong Lei China Chengyong Lei's profile →
Citations per field
00.5×2.9×
Chengyong Lei · 1×
Citations per year

Countries citing papers authored by Changjiang Qin

Since Specialization
Citations

This map shows the geographic impact of Changjiang Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjiang Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjiang Qin more than expected).

Fields of papers citing papers by Changjiang Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changjiang Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjiang Qin. The network helps show where Changjiang Qin may publish in the future.

Co-authorship network of co-authors of Changjiang Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Changjiang Qin. A scholar is included among the top collaborators of Changjiang Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjiang Qin. Changjiang Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 56
5 39
6 12
7 10
8 17
9 28
10 13
11 32
12 44
13 2
14 32
15 13
16 11
17 21

About Changjiang Qin

Changjiang Qin is a scholar working on Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 17 papers that have together received 335 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (4 papers), RNA modifications and cancer (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Cancer Research (132 citations), Molecular Biology (247 citations) and Urology (20 citations). Changjiang Qin has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Fangfang Hu, Xuequn Ren, Jiangtao Chen, Zhihui Xie, Yanru Zhang, Yanhua Li, Jianjun Wang, Jia‐Min Gu, Weiguang Li and Xian‐Tao Zeng. Their work appears in journals such as International Journal of Cancer, RSC Advances and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026